RE
Last reporting period 30 Sep, 2023
Updated —
Last price
—
Market cap $B
0.039
Exchange
XLON - London Stock Exchange
-0.0021 B
Last period CFO ,GBP
72%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also ReNeuron Group
Company Analysis
RENE.L valuation, rating, competitors, insights and company profile
Eyestock Rating
RENE.L financial analysis by Eyestock methodology
Valuation
RENE.L valuation using historical relative method
Statements
RENE.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
RENE.L dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
ReNeuron Group`s CFO for the period ended 2023-09-30 is -0.0021 B GBP
